Ikeda M, Okugawa S, Kashiwabara K, Moritoyo T, et al. Multicenter, Single-Blind, Randomized Controlled Study of the Efficacy and Safety of Favipiravir and Nafamostat Mesilate in Patients with COVID-19 Pneumonia. Int J Infect Dis 2023 Jan 3:S1201-9712(22)00684.
PMID: 36610659